233 related articles for article (PubMed ID: 34301385)
1. SARS-CoV-2 (COVID-19) in patients with some degree of immunosuppression.
Cajamarca-Baron J; Guavita-Navarro D; Buitrago-Bohorquez J; Gallego-Cardona L; Navas A; Cubides H; Arredondo AM; Escobar A; Rojas-Villarraga A
Reumatol Clin (Engl Ed); 2021; 17(7):408-419. PubMed ID: 34301385
[TBL] [Abstract][Full Text] [Related]
2. [SARS-CoV-2 (COVID-19) in Patients with some Degree of Immunosuppression].
Cajamarca-Baron J; Guavita-Navarro D; Buitrago-Bohorquez J; Gallego-Cardona L; Navas A; Cubides H; Arredondo AM; Escobar A; Rojas-Villarraga A
Reumatol Clin; 2021; 17(7):408-419. PubMed ID: 34630575
[TBL] [Abstract][Full Text] [Related]
3. Hepatic transplant during SARS-CoV-2 (COVID-19) pandemic. A literature review.
Pérez-González B; Thomas-Lora FC; Hoyo I; Flores-García NC; Rodríguez-Aguilar EF; Páez-Zayas VM; Márquez-Guillén E; Visag-Castillo V; García-Juárez I; Contreras AG
Cir Cir; 2021; 89(2):269-274. PubMed ID: 33784290
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcome of SARS-CoV-2 infection in immunosuppressed children in Spain.
Pérez-Martinez A; Guerra-García P; Melgosa M; Frauca E; Fernandez-Camblor C; Remesal A; Calvo C
Eur J Pediatr; 2021 Mar; 180(3):967-971. PubMed ID: 32860101
[TBL] [Abstract][Full Text] [Related]
5. Liver transplant immunosuppression during the covid-19 pandemic.
Forns X; Navasa M
Gastroenterol Hepatol; 2020 Oct; 43(8):457-463. PubMed ID: 32646657
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV2 and immunosuppression: A double-edged sword.
Lai Q; Spoletini G; Bianco G; Graceffa D; Agnes S; Rossi M; Lerut J
Transpl Infect Dis; 2020 Dec; 22(6):e13404. PubMed ID: 32639598
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 pneumonia in kidney transplant recipients: Focus on immunosuppression management.
Chen TY; Farghaly S; Cham S; Tatem LL; Sin JH; Rauda R; Ribisi M; Sumrani N
Transpl Infect Dis; 2020 Oct; 22(5):e13378. PubMed ID: 32573882
[TBL] [Abstract][Full Text] [Related]
8. Management of immunosuppressants in the era of coronavirus disease-2019.
Manansala M; Baughman R; Novak R; Judson M; Sweiss N
Curr Opin Pulm Med; 2021 May; 27(3):176-183. PubMed ID: 33779588
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 infection in kidney transplant recipients: Experience of the italian marche region.
Maritati F; Cerutti E; Zuccatosta L; Fiorentini A; Finale C; Ficosecco M; Cristiano F; Capestro A; Balestra E; Taruscia D; Vivarelli M; Donati A; Perna GP; Giacometti A; Tavio M; Onesta M; Di Sante L; Ranghino A
Transpl Infect Dis; 2020 Oct; 22(5):e13377. PubMed ID: 32573895
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 in solid organ transplant recipients: Dynamics of disease progression and inflammatory markers in ICU and non-ICU admitted patients.
Roberts MB; Izzy S; Tahir Z; Al Jarrah A; Fishman JA; El Khoury J
Transpl Infect Dis; 2020 Oct; 22(5):e13407. PubMed ID: 32654303
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies.
Goldman JD; Robinson PC; Uldrick TS; Ljungman P
J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34117116
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 Serologic Immune Response in Exogenously Immunosuppressed Patients.
Zilla ML; Keetch C; Mitchell G; McBreen J; Shurin MR; Wheeler SE
J Appl Lab Med; 2021 Mar; 6(2):486-490. PubMed ID: 33367709
[TBL] [Abstract][Full Text] [Related]
13. Attenuated early inflammatory response in solid organ recipients with COVID-19.
Bösch F; Börner N; Kemmner S; Lampert C; Jacob S; Koliogiannis D; Stangl M; Michel S; Kneidinger N; Schneider C; Fischereder M; Irlbeck M; Denk G; Werner J; Angele MK; Guba MO
Clin Transplant; 2020 Oct; 34(10):e14027. PubMed ID: 32589760
[TBL] [Abstract][Full Text] [Related]
14. Coronavirus Disease 2019 Pneumonia in Immunosuppressed Renal Transplant Recipients: A Summary of 10 Confirmed Cases in Wuhan, China.
Zhu L; Gong N; Liu B; Lu X; Chen D; Chen S; Shu H; Ma K; Xu X; Guo Z; Lu E; Chen D; Ge Q; Cai J; Jiang J; Wei L; Zhang W; Chen G; Chen Z
Eur Urol; 2020 Jun; 77(6):748-754. PubMed ID: 32317180
[TBL] [Abstract][Full Text] [Related]
15. Heart transplant recipients with confirmed 2019 novel coronavirus infection: The Detroit experience.
Al-Darzi W; Aurora L; Michaels A; Cowger J; Grafton G; Selektor Y; Tita C; Hannawi B; Lanfear D; Nemeh HW; Williams CT
Clin Transplant; 2020 Dec; 34(12):e14091. PubMed ID: 32940925
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 in Kidney Transplant Patients From a Large UK Transplant Center: Exploring Risk Factors for Disease Severity.
Sran K; Olsburgh J; Kasimatis T; Clark K; Gökmen R; Hilton R; Shah S; Shaw C; Farmer C; Kilbride H; Asgari E
Transplant Proc; 2021 May; 53(4):1160-1168. PubMed ID: 33483166
[TBL] [Abstract][Full Text] [Related]
17. Immunocompromised Seroprevalence and Course of Illness of SARS-CoV-2 in One Pediatric Quaternary Care Center.
Freeman MC; Rapsinski GJ; Zilla ML; Wheeler SE
J Pediatric Infect Dis Soc; 2021 Apr; 10(4):426-431. PubMed ID: 33049042
[TBL] [Abstract][Full Text] [Related]
18. Managing COVID-19 in Renal Transplant Recipients: A Review of Recent Literature and Case Supporting Corticosteroid-sparing Immunosuppression.
Johnson KM; Belfer JJ; Peterson GR; Boelkins MR; Dumkow LE
Pharmacotherapy; 2020 Jun; 40(6):517-524. PubMed ID: 32339304
[TBL] [Abstract][Full Text] [Related]
19. Successful recovery from severe COVID-19 pneumonia after kidney transplantation: The interplay between immunosuppression and novel therapy including tocilizumab.
Lauterio A; Valsecchi M; Santambrogio S; De Carlis R; Merli M; Calini A; Centonze L; Buscemi V; Bottiroli M; Puoti M; Fumagalli R; De Carlis L
Transpl Infect Dis; 2020 Oct; 22(5):e13334. PubMed ID: 32449235
[TBL] [Abstract][Full Text] [Related]
20. Humoral response to COVID-19 infection in immunosuppressed patients with inflammatory bowel disease.
Scharrer S; Kutschera M; Weseslindtner L; Primas C; Vogelsang H
Eur J Gastroenterol Hepatol; 2021 Mar; 33(3):443-447. PubMed ID: 33522752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
